ask="0.740"
ask_size="200"
average_daily_volume="147102"
bid="N/A"
bid_size="N/A"
book_value="0.725"
change="+0.059"
change_from_200_day_moving_average="-0.657"
change_from_50_day_moving_average="-0.364"
change_from_52_week_high="-1.341"
change_From_52_week_low="0.099"
change_in_percent="+9.833%"
close="0.659"
dividend_pay_date="11/8/2012"
dividend_per_share="0.000"
dividend_yield="0.000"
earnings_per_share="-0.810"
ebitda="-30.60M"
eps_estimate_current_year="-0.930"
eps_estimate_next_quarter="-0.230"
eps_estimate_next_year="-0.860"
ex_dividend_date="11/9/2012"
float_shares="30530000"
high="0.690"
high_52_weeks="2.000"
last_trade_date="3/3/2017"
last_trade_price="0.659"
last_trade_size="846"
last_trade_time="4:00pm"
low="0.573"
low_52_weeks="0.560"
market_capitalization="25.47M"
moving_average_200_day="1.316"
moving_average_50_day="1.023"
name="Aviragen Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.170"
open="0.620"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-49.922%"
percent_change_from_50_day_moving_average="-35.597%"
percent_change_from_52_week_high="-67.050%"
percent_change_from_52_week_low="+17.679%"
previous_close="0.600"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.828"
price_per_sales="2.366"
revenue="9.80M"
shares_outstanding="38649000"
short_ratio="1.370"
stock_exchange="NMS"
symbol="AVIR"
volume="303819"
weeks_range_52="0.560 - 2.000"
